Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
861.7 DKK | -0.12% | -2.05% | +23.48% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 15 | More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.48% | 550B | |
+27.97% | 672B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.36% | 211B | |
-0.42% | 203B | |
-9.98% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk Q4 Earnings, Sales Rise; Issues 2023 Outlook; to Start 28 Billion Kroner Share Buyback Program